Gestational Trophoblastic Tumor

Observed

→ investigated in trials for

Dactinomycinother

7 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Alemtuzumabmonoclonal antibody

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Chemotherapy

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cyclophosphamidesmall_molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Leucovorinsmall_molecule

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pembrolizumabmonoclonal_antibody

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pemetrexedsmall_molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Toripalimabmonoclonal_antibody

2 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Aldesleukinother

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Bevacizumabmonoclonal_antibody

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Camrelizumabmonoclonal_antibody

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Carboplatinsmall_molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cisplatinsmall_molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Dexamethasonesmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Dostarlimabmonoclonal_antibody

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Etoposidesmall_molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Filgrastimother

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ipilimumabmonoclonal antibody

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Letrozolesmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Nivolumabmonoclonal antibody

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Paclitaxelsmall_molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Prednisonesmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Vincristinesmall_molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

Gestational Trophoblastic Tumor studied in …STUDIED_INderived10 of 61show all (up to 200)
→ studied in	NCT06339827NA · completed ASk Questions in GYnecologic Oncology (ASQ-GYO) · condition mapped ALIAS · 61 trials mapped (15 active)	—	—	Gestational Trophoblastic Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT03703271Phase 3 · recruiting Study of Hysteroscopic Repeat Curettage as the First-line Treatment in Low-risk Postmolar Gestational Trophoblastic Neoplasia · condition mapped ALIAS · 61 trials mapped (15 active)	—	—	Gestational Trophoblastic Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT06790706Phase 2 · active not recruiting IMMUNORARE5: A National Platform of 5 Academic Phase II Trials Coordinated by Lyon University Hospital to Assess the Safety and the Efficacy of the IMMUNOtherapy With Domvanalimab + Zimberelimab Combination in Patients With Advanced RARE Cancers · condition mapped ONTOLOGY_EXACT · 61 trials mapped (15 active)	—	—	Gestational Trophoblastic Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT02834013Phase 2 · active not recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors · condition mapped ONTOLOGY_EXACT · 61 trials mapped (15 active)	—	—	Gestational Trophoblastic Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT01008501active not recruiting Study of the Genetic and Epigenetic Causes of Recurrent Hydatidiform Moles · condition mapped ALIAS · 61 trials mapped (15 active)	—	—	Molar Pregnancy	1	Observed	clinicaltrials	graph →
→ studied in	NCT03785574NA · recruiting Study of Different Therapeutic Strategies in Hydatidiform Mole With Lung Nodule · condition mapped ALIAS · 61 trials mapped (15 active)	—	—	Gestational Trophoblastic Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT05139095Phase 2 · recruiting Camrelizumab Plus Apatinib in Patients With High-risk Gestational Trophoblastic Neoplasia · condition mapped ALIAS · 61 trials mapped (15 active)	—	—	Gestational Trophoblastic Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT07333326not yet recruiting Uterine Artery Doppler Flow Velocimetry Parameters for Predicting the Occurrence of Persistent Gestational Trophoblastic Neoplasia After Evacuation of Complete Hydatiform Mole · condition mapped ALIAS · 61 trials mapped (15 active)	—	—	Gestational Trophoblastic Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT07202728recruiting A Multi-center Cohort Study of Hydatidiform Mole in China (CN-HM-01) · condition mapped ALIAS · 61 trials mapped (15 active)	—	—	Molar Pregnancy	1	Observed	clinicaltrials	graph →
→ studied in	NCT04562558NA · active not recruiting Biweekly Actinomycin-D Treatment or Multi-day Methotrexate Protocol in Low-risk Gestational Trophoblastic Neoplasia · condition mapped ONTOLOGY_EXACT · 61 trials mapped (15 active)	—	—	Gestational Trophoblastic Tumor	1	Observed	clinicaltrials	graph →

Gestational Trophoblastic Tumor studied in …STUDIED_INderived10 of 61show all (up to 200)

→ studied in

NCT06339827NA · completed

ASk Questions in GYnecologic Oncology (ASQ-GYO) · condition mapped ALIAS · 61 trials mapped (15 active)

—

Observed

→ studied in

NCT03703271Phase 3 · recruiting

Study of Hysteroscopic Repeat Curettage as the First-line Treatment in Low-risk Postmolar Gestational Trophoblastic Neoplasia · condition mapped ALIAS · 61 trials mapped (15 active)

—

Observed

→ studied in

NCT06790706Phase 2 · active not recruiting

IMMUNORARE5: A National Platform of 5 Academic Phase II Trials Coordinated by Lyon University Hospital to Assess the Safety and the Efficacy of the IMMUNOtherapy With Domvanalimab + Zimberelimab Combination in Patients With Advanced RARE Cancers · condition mapped ONTOLOGY_EXACT · 61 trials mapped (15 active)

—

Observed

→ studied in

NCT02834013Phase 2 · active not recruiting

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors · condition mapped ONTOLOGY_EXACT · 61 trials mapped (15 active)

—

Observed

→ studied in

NCT01008501active not recruiting

Study of the Genetic and Epigenetic Causes of Recurrent Hydatidiform Moles · condition mapped ALIAS · 61 trials mapped (15 active)

—

Molar Pregnancy

Observed

→ studied in

NCT03785574NA · recruiting

Study of Different Therapeutic Strategies in Hydatidiform Mole With Lung Nodule · condition mapped ALIAS · 61 trials mapped (15 active)

—

Observed

→ studied in

NCT05139095Phase 2 · recruiting

Camrelizumab Plus Apatinib in Patients With High-risk Gestational Trophoblastic Neoplasia · condition mapped ALIAS · 61 trials mapped (15 active)

—

Observed

→ studied in

NCT07333326not yet recruiting

Uterine Artery Doppler Flow Velocimetry Parameters for Predicting the Occurrence of Persistent Gestational Trophoblastic Neoplasia After Evacuation of Complete Hydatiform Mole · condition mapped ALIAS · 61 trials mapped (15 active)

—

Observed

→ studied in

NCT07202728recruiting

A Multi-center Cohort Study of Hydatidiform Mole in China (CN-HM-01) · condition mapped ALIAS · 61 trials mapped (15 active)

—

Molar Pregnancy

Observed

→ studied in

NCT04562558NA · active not recruiting

Biweekly Actinomycin-D Treatment or Multi-day Methotrexate Protocol in Low-risk Gestational Trophoblastic Neoplasia · condition mapped ONTOLOGY_EXACT · 61 trials mapped (15 active)

—

Observed